Shares of Bright Minds Biosciences rose after the company released positive topline results from its phase two trial of a treatment for patients with drug-resistant Absence Seizures and Developmental ...

BMB-101 demonstrated significant anti-seizure benefit in both cohorts with favorable safety and tolerability Absence: 73.1% ...

(NewsNation) — March 26 is Purple Day, a day dedicated to raising awareness about epilepsy worldwide. An estimated 50 million people worldwide are diagnosed with epilepsy, and seizures are the main ...

Bright Minds Biosciences ( ($TSE:DRUG) ) has issued an update. On January 5, 2026, Bright Minds Biosciences announced plans to report topline ...

Bright Minds Biosciences (DRUG) stock jumps as lead drug BMB-101 succeeds in a mid-stage trial against a severe neurological ...

Q: My child was staring off into space, and I thought he just wasn’t paying attention. He didn’t respond to his name and seemed frozen for about 10 seconds, then just resumed playing like nothing ...

The areas of the cerebral cortex that are affected in mice with absence epilepsy have been pinpointed by research that also shows that transplanting embryonic neural cells into these areas can ...

At first, the teacher described her six-year-old student as absentminded, a daydreamer. The boy was having difficulty paying attention in class. As the teacher watched the boy closely, she realized ...

Changes Clinical Practice: In children with absence epilepsy, ethosuximide should be preferred as the first-line anticonvulsant. Childhood absence epilepsy is one of the most common epilepsy syndromes ...

New contributions to the field of epilepsy have opened a window into the cellular events that occur in the brain during absence seizures. At first, the teacher described her six-year-old student as ...